Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

L Klimek1, U Förster-Ruhrmann2, H Olze2

  • 1Zentrum für Rhinologie und Allergologie, Wiesbaden.

Laryngo- Rhino- Otologie
|February 7, 2023
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the interpretation of neck CT/MRI scans by ChatGPT-4V for detecting primary oropharyngeal squamous cell carcinoma: An exploratory study.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].

Laryngo- rhino- otologie·2026
Same author

Lack of De-Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis.

Cancer medicine·2026
Same author

[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 3: Hypersensitivity reactions of type VI].

HNO·2026
Same author

[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)].

HNO·2025
Same author

Olfactory implants: international opinion paper on emerging technologies and clinical applications.

Rhinology·2025
Same journal

Guideline-Based Cochlear Implant Care: A Model for Structuring Delegated Technical Aftercare.

Laryngo- rhino- otologie·2026
Same journal

Audiometric evaluation and quality-of-life in OSIA users - a retrospective monocentric study.

Laryngo- rhino- otologie·2026
Same journal

[Diagnosis and treatment of vestibular migraine - recent developments and future treatment strategies].

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
See all related articles
Summary
This summary is machine-generated.

Mepolizumab offers a new biologic therapy for severe chronic rhinosinusitis with nasal polyps (CRSwNP). This study provides essential recommendations for monitoring, therapy intervals, and discontinuation of mepolizumab treatment in CRSwNP patients.

Area of Science:

  • Immunology
  • Pharmacology

Context:

  • Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex inflammatory condition.
  • Eosinophilic inflammation is a key endotype in CRSwNP.
  • Mepolizumab, an anti-IL5 antibody, is approved for severe CRSwNP unresponsive to conventional treatments.

Purpose:

  • To establish guidelines for monitoring mepolizumab therapy in CRSwNP.
  • To define protocols for therapy adherence, intervals, and potential breaks.
  • To provide recommendations for the discontinuation of mepolizumab when necessary.

Summary:

  • A literature review and expert consensus informed the development of practical recommendations.
  • The guidelines address follow-up, adherence, and termination criteria for mepolizumab in CRSwNP.

Related Experiment Videos

  • A documentation sheet is proposed to support consistent therapy management.

    • Impact:

    • Facilitates optimal use of mepolizumab for severe CRSwNP patients.
    • Ensures appropriate patient management and resource allocation within the German healthcare system.
    • Supports clinicians in making informed decisions regarding biologic therapy for CRSwNP.